Merck to price bond amid CEO exit

Merck, the German pharmaceuticals company, has forged ahead with the sale of a €500m ($590m) bond despite the departure of its chief executive.

The company said on Tuesday evening that chief executive Bernard Scheuble had been replaced by board member Michael Roemer.

WSJ Logo
Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With TrumpExternal link

Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With Trump